Story thread · 2 reports / 1 sources
Pulmovant to present phase 2 mosliciguat study results Tuesday
investing.com · 9d
First report: Roivant to present phase 2 pulmonary hypertension study results — investing.com, 9d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.